Related Experiment Video
Updated: Jul 11, 2025

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
[Systemic therapies for advanced thyroid cancer - an update]
Tim Brandenburg1,2, Yara Maria Machlah1,2, Dagmar Führer-Sakel1,2
1Klinik für Endokrinologie, Diabetologie und Stoffwechsel, Universitätsklinikum Essen, Essen, Germany.
Four multi-kinase inhibitors (MKI) treat advanced thyroid cancer in Germany. Recent approvals include Cabozantinib for radioiodine-refractory DTC and Selpercatinib for MTC and DTC, offering new targeted treatment options.
Area of Science:
- Oncology
- Pharmacology
- Clinical Medicine
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Therapy
Antianxiety Medications
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

